The US Food and Drug Administration (FDA) has issued a warning to patients and healthcare providers that certain Medtronic MiniMed some insulin pumps carry cybersecurity risks.
The alert reads, in part, as follows:
"The FDA has become aware than an unauthorized person (someone other than a patient, patient caregiver, or health care provider) could potentially connect wirelessly to a nearby MiniMed insulin pump with cybersecurity vulnerabilities and change the pump's settings to either over-deliver insulin to a patient, leading to low blood sugar (hypoglycemia), or stop insulin delivery, leading to high blood sugar and diabetic ketoacidosis.